Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Clodronic acid
Drug ID BADD_D00494
Description Clodronic acid is a first generation bisphosphonate similar to [etidronic acid] and [tiludronic acid].[A203111] These drugs were developed to mimic the action of pyrophosphate, a regulator of calcification and decalcification.[A1923] clodronate’s use has decreased over the years in favor of the third generation, nitrogen containing bisphosphonate [zoledronic acid], [ibandronic acid], [minodronic acid], and [risedronic acid].[A203111] Clodronic acid is not FDA approved, but is approved in Canada.[L13910]
Indications and Usage For the management of hypercalcemia of malignancy and as an adjunct in the management of osteolysis resulting from bone metastases of malignant tumors.
Marketing Status Not Available
ATC Code M05BA02
DrugBank ID DB00720
KEGG ID D03545
MeSH ID D004002
PubChem ID 25419
TTD Drug ID D00HNB
NDC Product Code Not Available
Synonyms Clodronic Acid | Acid, Clodronic | Dichloromethane Diphosphonate | Diphosphonate, Dichloromethane | Dichloromethylenebisphosphonate | Dichloromethanediphosphonic Acid | Acid, Dichloromethanediphosphonic | Dichloromethylene Biphosphonate | Biphosphonate, Dichloromethylene | Dichloromethylene Diphosphonate | Diphosphonate, Dichloromethylene | Cl2MDP | Dichloromethanediphosphonate | Clodronate | Clodronate Disodium | Disodium, Clodronate | Clodronate Sodium | Sodium, Clodronate | Bonefos
Chemical Information
Molecular Formula CH4Cl2O6P2
CAS Registry Number 10596-23-3
SMILES C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Nausea07.01.07.001--
Neoplasm malignant16.16.01.001--Not Available
Nephrocalcinosis20.04.01.001--Not Available
Oliguria20.01.03.004--Not Available
Pharyngitis07.05.07.004; 22.07.03.004; 11.01.13.003--
Pneumonia22.07.01.003; 11.01.09.003--Not Available
Proteinuria20.02.01.011--
Pruritus23.03.12.001--
Rash23.03.13.001--Not Available
Renal failure20.01.03.005--Not Available
Skin disorder23.03.03.007--Not Available
Type I hypersensitivity10.01.03.006--Not Available
Urethral disorder20.07.01.002--Not Available
Urinary tract disorder20.08.01.001--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Vomiting07.01.07.003--
Wheezing22.03.01.009--
Foetor hepaticus09.01.05.006; 07.01.06.026--Not Available
Protein urine present13.13.02.006--Not Available
Hepatic cancer metastatic16.07.02.002; 09.04.02.006--Not Available
Connective tissue disorder15.06.01.006--Not Available
Mediastinal disorder22.09.03.001--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
Renal impairment20.01.03.010--Not Available
Osteonecrosis of jaw24.04.05.005; 15.02.04.010--
Oral disorder07.05.01.005--Not Available
Acute kidney injury20.01.03.016--
The 2th Page    First    Pre   2    Total 2 Pages